Skip to main content

Table 2 Life table for OS, DP, LC

From: Stereotactic body radiotherapy (SBRT) in patients with lung metastases - prognostic factors and long-term survival using patient self-reported outcome (PRO)

 

Proportion surviving after

1-year

2-year

3-year

4-year

5-year

10-year

OS

74%

54%

39%

29%

26%

17%

DP

58%

46%

40%

37%

34%

32%

LC

92%

84%

78%

77%

75%

75%

  1. OS Overall survival, DP Distant progression, LC Local control
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us